Multidrug resistance (MDR) in acute myeloid leukemia (AML) with core-binding factor (CBF) abnormalities.

被引：0
|
作者：
Baer, MR [1 ]
O'Loughlin, KL [1 ]
Minderman, H [1 ]
Sait, SN [1 ]
Flood, JJ [1 ]
Sorci, JJ [1 ]
Stewart, CC [1 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
273
引用
收藏
页码：64A / 64A
页数：1
相关论文
共 50 条
  • [31] Prognostic of Core Binding Factor (CBF) Acute Myeloid Leukemia With Complex Karyotype
    Marcault, Clemence
    Boissel, Nicolas
    Haferlach, Claudia
    Loschi, Michael
    Raynaud, Sophie
    Cluzeau, Thomas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (03): : E199 - E205
  • [32] ACUTE MYELOID LEUKEMIA CORE-BINDING-FACTOR (CBF): EXPERIENCE IN A CENTER
    Cornago, Navascues Javier
    Pardo, Gambarte Laura
    Lopez, Lorenzo Jose Luis
    Solan, Blanco Laura
    Soto, de Ozaeta Carlos
    Blas, Lopez Carlos
    Alonso, Dominguez Juan Manuel
    Atance, Pasarisas Mireia
    Salgado, Sanchez Rocio
    Llamas, Sillero P.
    HAEMATOLOGICA, 2020, 105 : 222 - 222
  • [33] VARIANT ALLELE FREQUENCY KINETICS OF TYROSINE KINASE GENE MUTATIONS IN CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA (CBF-AML) UNDER TREATMENT WITH AND WITHOUT DASATINIB
    Agrawal, M.
    Jahn, N.
    Dolnik, A.
    Cocciardi, S.
    Schmalbrock, L. K.
    Blaette, T. J.
    Gaidzik, V.
    Luebbert, M.
    Fiedler, W.
    Fischer, T.
    Brossart, P.
    Wattad, M.
    Thol, F.
    Heuser, M.
    Ganser, A.
    Schlenk, R. F.
    Paschka, P.
    Doehner, H.
    Doehner, K.
    Bullinger, L.
    HAEMATOLOGICA, 2017, 102 : 204 - 205
  • [34] Prospective Evaluation of Prognostic Relevance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: Results from the JALSG CBF-AML209-KIT Study
    Kawashima, Naomi
    Ishikawa, Yuichi
    Atsuta, Yoshiko
    Sugiura, Isamu
    Sawa, Masashi
    Dobashi, Nobuaki
    Yokoyama, Hisayuki
    Doki, Noriko
    Tomita, Akihiro
    Kiguchi, Toru
    Koh, Shiro
    Kanamori, Heiwa
    Iriyama, Noriyoshi
    Kohno, Akio
    Moriuchi, Yukiyoshi
    Asada, Noboru
    Hirano, Daiki
    Togitani, Kazuto
    Sakura, Toru
    Hagihara, Maki
    Tomikawa, Tatsuki
    Yokoyama, Yasuhisa
    Asou, Norio
    Ohtake, Shigeki
    Matsumura, Itaru
    Miyazaki, Yasushi
    Naoe, Tomoki
    Kiyoi, Hitoshi
    BLOOD, 2018, 132
  • [35] Response Kinetics and Factors Predicting Survival Among Patients with Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)
    Boddu, Prajwal
    Gurguis, Christopher
    Cortes, Jorge E.
    Akosile, Mary
    Ravandi, Farhad
    Sanford, David
    Brandt, Mark
    Maduike, Rita
    Kadia, Tapan
    Kantarjian, Hagop M.
    Borthakur, Gautam
    BLOOD, 2017, 130
  • [36] Clonal Interference of Signaling Mutations Holds Prognostic Relevance in Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)
    Itzykson, Raphael
    Duployez, Nicolas
    Fasan, Annette
    Marceau-Renaut, Alice
    Meggendorfer, Manja
    Jourdan, Eric
    Petit, Arnaud
    Lapillonne, Helene
    Micol, Jean-Baptiste
    Cornillet-Lefebvre, Pascale
    Ifrah, Norbert
    Leverger, Guy
    Dombret, Herve
    Boissel, Nicolas
    Haferlach, Torsten
    Preudhomme, Claude
    BLOOD, 2017, 130
  • [37] Clinical Outcomes of Adults With Core Binding Factor Acute Myeloid Leukemia (CBF-AML): A Single Center Experience
    Chan, Kok Hoe
    Yohannan, Binoy
    Sridhar, Arthi
    Rios, Adan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S289 - S289
  • [38] DASATINIB (DAS) IN COMBINATION WITH CHEMOTHERAPY AND AS MAINTENANCE IN CORE-BINDING FACTOR (CBF) ACUTE MYELOID LEUKEMIA (AML): A PHASE IB/IIA STUDY OF THE GERMAN-AUSTRIAN AML STUDY GROUP (AMLSG)
    Paschka, P.
    Schlenk, R. F.
    Weber, D.
    Fiedler, W.
    Luebbert, M.
    Theobald, M.
    Greil, R.
    Horst, H. -A.
    Krauter, J.
    Salih, H. R.
    Heil, G.
    Martens, U.
    Kuendgen, A.
    Brossart, P.
    Heuser, M.
    Gaidzik, V. I.
    Thol, F.
    Goehring, G.
    Ganser, A.
    Doehner, K.
    Doehner, H.
    HAEMATOLOGICA, 2015, 100 : 194 - 195
  • [39] Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors
    Duployez, Nicolas
    Willekens, Christophe
    Marceau-Renaut, Alice
    Boudry-Labis, Elise
    Preudhomme, Claude
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (01) : 43 - 56
  • [40] No evidence for core-binding factor CBFβ as a leukemia predisposing factor in chromosome 16q22-linked familial AML
    R Escher
    F Hagos
    J Michaud
    L Sveen
    M Horwitz
    O I Olopade
    H S Scott
    Leukemia, 2004, 18 : 881 - 881
12345